Born in Cuba to a family of medical doctors, Noel enrolled in medical school at the age of 17 and attended for 5 out of the required 6 years of the medical curriculum. Due to the political situation in Cuba, Noel and his family sought to escape communism and were forced to immigrate to Miami, Florida. Once in the US, he had to restart his higher education and went to pursue a degree in Biology at the State University of New York in Buffalo, where he fell in love with genetics. He then moved to San Diego, California to work in stem cell research (Salk Institute, University of California San Diego, Scripps), and later pursued a PhD at the Ludwig Maximilian University - Helmholtz Zentrum in Munich, Germany, where he completed 6yrs of doctorate research in stem cell differentiation towards pancreatic islets to treat diabetic patients. He obtained a PhD with honors (magna cum laude- degree earned with notable distinction), due to his contribution in the work with gastrine and CCK in early pancreatic islet formation. He’s also published author and co-author in major scientific journals (Cell, Stem Cell Report, The CRISPR Journal) covering his work in stem cell differentiation and gene editing research topics.
When Noel’s father was diagnosed with Stage 4 colon cancer, he realized that there is a great disconnect between the scientific research and medical field. Unfortunately, his father passed away, which was incredibly painful but also a wake up moment for him and an inspiration to build delphistem.
Upon his return to the US, he joined a research team at Emory University in Atlanta, where he worked in differentiating human stem cells towards the heart aiming to generate a biological pacemaker.
However, his passion about making innovative biomedical technologies accessible to everyone led him to co-creating delphistem.
Noel is heading the vision, science and technology part of the business, as CEO, Chief Science & Technology Officer.
He can be reached at @DrNoelMoya or via email